1. Search Result

Search Result

Results for "250694-07-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-16482

    Endogenous Metabolite Metabolic Disease
    Teglicar is a selective and reversible inhibitor of liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). Teglicar reduces ketogenesis and glucose production, decreases gluconeogenesis and improves glucose homeostasis. Teglicar has a potential antihyperglycemic propert.